Genes & Cancer
Overview
Genes & Cancer is a peer-reviewed scientific journal that focuses on the latest advancements in cancer research, with a particular emphasis on the role of genes in the development, progression, and treatment of various types of cancer. The journal publishes original research articles, reviews, and commentaries, providing a comprehensive platform for scientists and clinicians to exchange knowledge and insights in the field of cancer genetics and genomics.
Details
Details
Abbr.
Genes Cancer
Start
2010
End
Continuing
Frequency
Monthly
p-ISSN
1947-6019
e-ISSN
1947-6027
Country
United States
Language
English
Specialty
Oncology
Metrics
Metrics
h-index / Ranks: 4277
81
SJR / Ranks: 8077
559
CiteScore / Ranks: 4778
5.20
Recent Articles
1.
Azimi Y, Hajibabaei S, Azimi G, Rahimi-Jamnani F, Azizi M
Genes Cancer
. 2025 Jan;
16:16-17.
PMID: 39881962
[This corrects the article DOI: 10.18632/genesandcancer.236.].
2.
Pena-Balderas A, Martinez-Sanchez M, Olmos-Sanchez I, Calderon-Gonzalez K, Moctezuma-Davila M, Rangel-Charqueno M, et al.
Genes Cancer
. 2025 Jan;
16():1-15.
PMID: 39845333
is a gene that codes for a tumour suppressor protein involved in various types of cancer. It was first described in retinoblastoma and is segregated as an autosomal dominant trait...
3.
Nazmeen A, Maiti S, Maiti S
Genes Cancer
. 2024 Aug;
15:41-59.
PMID: 39132498
Background: In some breast cancers, altered estrogen-sulfotransferase (SULT1E1) and its inactivation by oxidative-stress modifies E2 levels. Parallelly, hypoxia-inducible tissue-damaging factors (HIF1α) are induced. The proteins/genes expressions of these factors were...
4.
Azimi Y, Hajibabaei S, Azimi G, Rahimi-Jamnani F, Azizi M
Genes Cancer
. 2024 May;
15:28-40.
PMID: 38756697
The MYC gene is a regulatory and proto-oncogenic gene that is overexpressed in the majority of prostate cancers (PCa). Numerous studies have indicated that aberrant expression of microRNAs is involved...
5.
Jayabal P, Ma X, Shiio Y
Genes Cancer
. 2024 Feb;
15:15-27.
PMID: 38323120
Ewing sarcoma is a cancer of bone and soft tissue in children and young adults that is driven by the EWS-ETS fusion transcription factor, most commonly EWS-FLI1. We previously reported...
6.
Xiang X, Bhowmick K, Shetty K, Ohshiro K, Yang X, Wong L, et al.
Genes Cancer
. 2024 Feb;
15():1-14.
PMID: 38323119
Hepatocellular carcinoma (HCC) is the third leading cause of death from cancer worldwide but is often diagnosed at an advanced incurable stage. Yet, despite the urgent need for blood-based biomarkers...
7.
8.
Drumond-Bock A, Wang L, Wang L, Cybula M, Rostworowska M, Kinter M, et al.
Genes Cancer
. 2023 Sep;
14:56-76.
PMID: 37705995
Chemoresistance in ovarian carcinoma is a puzzling issue that urges understanding of strategies used by cancer cells to survive DNA damage and to escape cell death. Expanding efforts to understand...
9.
Zahra K, Cherif W, Ahmed G, Regaieg H, Nesrine B, Zaier M, et al.
Genes Cancer
. 2023 Jul;
14:50-55.
PMID: 37427149
The t (8; 21) (q22; q22) with the resulting RUNX1- RUNX1T1 rearrangement is one of the most common cytogenetic abnormalities in acute myeloid leukemia (AML). It is associated with favorable...
10.
Lee Y, Klomp J, Stalnecker C, Goodwin C, Gao Y, Droby G, et al.
Genes Cancer
. 2023 Mar;
14:30-49.
PMID: 36923647
We and others have recently shown that proteins involved in the DNA damage response (DDR) are critical for -mutant pancreatic ductal adenocarcinoma (PDAC) cell growth . However, the CRISPR-Cas9 library...